glp-1 obesity drug news today 2025 A nice article in The Hindu today highlights the The World Health Organization is

Diabetes Ther (2021) 12:320115

You may notice an increase in appetite and a return of food cravings, allowing you to eat more without feeling as full

Albiglutide, a long-acting GLP-1 receptor agonist, improves glycemia in type 2 diabetes: time-course analysis [abstract]

Amjad S, Nisar S, Bhat AA, Shah AR, Frenneaux MP, Fakhro K, et al

Patients with significant gallstone risk may start with semaglutide or use a Microdose GLP-1 Protocol ($129/month) to minimize rapid weight loss, then transition to tirzepatide once weight loss stabilizes

Internal Revenue Service (IRS) outlines its criteria for semaglutide as a health expense under Publication 502